University of Michigan researchers have found that metformin, a common diabetes medication, may help reduce atrial fibrillation (Afib) episodes in adults with obesity after ablation procedures. In the study, participants taking metformin experienced fewer Afib episodes and needed fewer repeat procedures than those who did not. Read the full article to learn how these findings could lead to new treatment options for Afib in patients with obesity.
